BCR and atherosclerosis: In ABC CD11c+ B cells, DEG and IPA suggested that BCR signalling may be enriched in cells from patients with severe atherosclerosis, as exemplified by higher expression of Itgax (CD11c), a marker of activation, and lower expression of Cd72, an inhibitor of BCR signalling [15].